MeSH Browser

MeSH Heading: Clorazepate Dipotassium
Tree Number(s): D03.633.100.079.080.180
Unique ID: D003009
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D003009
Scope Note: A water-soluble benzodiazepine derivative effective in the treatment of anxiety. It has also muscle relaxant and anticonvulsant actions.
Entry Term(s): 4306-CB; Chlorazepate; Clorazepate; Clorazepate Monopotassium; Clorazepic Acid; Dipotassium Chlorazepate; Tranxene; Tranxilium
Pharm Action: Anticonvulsants
Anti-Anxiety Agents
GABA Modulators
Registry Numbers: 63FN7G03XY; MS63G8NQUI; 0; D51WO0G0L4
Related Numbers: 57109-90-7; D51WO0G0L4; MS63G8NQUI
CAS Type 1 Name: 1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, monopotassium salt, compd. with potassium hydroxide (K(OH)) (1:1)
Previous Indexing: Benzazepines (1971-1974); Carboxylic Acids (1971-1974)
Public MeSH Note: 1991; was see under BENZODIAZEPINE TRANQUILIZERS 1975-1990
History Note: 1991 (1975); was see under BENZODIAZEPINE TRANQUILIZERS 1975-1990
Date Established: 1991/01/01
Date of Entry: 1974/11/11
Revision Date: 2018/05/21

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Clorazepate Dipotassium MeSH Descriptor Data 2025